Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Narrow Gauge Ventures is a venture capital firm based in the United States, focused on addressing inefficiencies in the U.S. healthcare system. The firm targets early and middle-stage companies, emphasizing capital efficiency and proven revenue. They currently manage a portfolio of four companies.
Narrow Gauge Ventures invests in pre-seed to Series B healthcare and biotech companies. They seek businesses with strong teams and a commitment to sustainable growth, particularly those utilizing technology to improve healthcare practices and delivery models.
Notable companies in Narrow Gauge Ventures' portfolio include rMark Bio, which advances life sciences; Agathos, providing data-driven insights for hospital physicians; Ripple, enhancing communication in clinical studies; and Navv, offering real-time operational data for hospitals.
Submit your pitch through their form at narrowgaugeventures.com.
Yes, Narrow Gauge Ventures often leads investment rounds in their target companies, particularly in early and middle stages.
The firm is open to follow-on investments, especially in companies that demonstrate strong growth and capital efficiency.
Specific fund size details are not disclosed, but the firm focuses on capital-efficient investments in healthcare.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.